跳至主要内容
临床试验/DRKS00026030
DRKS00026030招募中未知

Effect of a modest salt reduction on blood pressure and surrogate markers of cardiovascular damage in patients with primary aldosteronism.

Medizinische Klinik und Poliklinik IV, LMU Klinikum München0 个研究点目标入组 38 人开始时间: 2021年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • diagnosis of primary aldosteronism with specific treatment using mineralocorticoid receptor antagonists
  • - written informed consent

排除标准

  • - severe comobidities
  • - age below 18 years
  • - intended lifestyle changes (e.g. sports)
  • - pregnancy, or planned pragnancy within the next 6 months
  • - surgery or planned surgery within the next 6 months
  • - cardiac infarction or stroke within the last 6 months
  • - recently performed radiation or chemotherapy
  • - alcohol abuse or illegal drug use within the last 6 months
  • - active smoking status
  • - severe dietary restrictions/allergies
  • - other secondary causes of hypertension
  • - no possiibility for informent consent

研究者

发起方
Medizinische Klinik und Poliklinik IV, LMU Klinikum München

相似试验

Effect of a modest salt reduction on blood pressure... | 临床试验